BioCircuit Technologies
BioCircuit Technologies is dedicated to translating cutting-edge neurotechnology research into practical clinical tools. The company focuses on developing tools for neural interfacing and tissue repair, empowering clinicians with advanced solutions for diagnosing and treating injuries and diseases. Headquartered in Atlanta, GA, BioCircuit is supported by the National Institutes of Health and healthcare technology investors.
BioCircuit Technologies
1819 Peachtree Rd NE, Suite 205, Atlanta, Georgia 30309
What We Do
Non-invasive monitoring and control of nerve and muscle activity using specialized skin-surface electrode arrays and custom multichannel electronics. This platform enhances the ability to diagnose and treat diseases by providing a high-definition view of nerve activity.
Nerve Tape is the first FDA-cleared sutureless device for nerve repair. It is designed to easily repair and connect transected nerves without the need for microsutures, using Porcine Small Intestinal Submucosa and Nitinol Microhooks for a strong mechanical attachment.
Regenerative Medicine
Key People
Board Chair
News & Updates
Funding will extend the Nerve Tape product line and accelerate clinical adoption.
Nerve Tape receives FDA 510(k) clearance, becoming the first sutureless nerve repair device.